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Background: The gaseous headspace above naïve Escherichia Coli (E. coli) cultures and whole human blood
inoculated with E. coli were collected and analyzed for the presence of trace gases that may have the potential to
be used as novel, non-invasive markers of infectious disease.
Methods: The naïve E. coli culture, LB broth, and human whole blood or E. coli inoculated whole blood were
incubated in hermetically sealable glass bioreactors at 37°C for 24 hrs. LB broth and whole human blood were used
as controls for background volatile organic compounds (VOCs). The headspace gases were collected after
incubation and analyzed using a gas chromatographic system with multiple column/detector combinations.
Results: Six VOCs were observed to be produced by E. coli-infected whole blood while there existed nearly zero to
relatively negligible amounts of these gases in the whole blood alone, LB broth, or E. coli-inoculated LB broth.
These VOCs included dimethyl sulfide (DMS), carbon disulfide (CS2), ethanol, acetaldehyde, methyl butanoate, and
an unidentified gas S. In contrast, there were several VOCs significantly elevated in the headspace above the E. coli
in LB broth, but not present in the E. coli/blood mixture. These VOCs included dimethyl disulfide (DMDS), dimethyl
trisulfide (DMTS), methyl propanoate, 1-propanol, methylcyclohexane, and unidentified gases R2 and Q.
Conclusions: This study demonstrates 1) that cultivated E. coli in LB broth produce distinct gas profiles, 2) for the
first time, the ability to modify E. coli-specific gas profiles by the addition of whole human blood, and 3) that E. coli-
human whole blood interactions present different gas emission profiles that have the potential to be used as non-
invasive volatile biomarkers of E. coli infection.
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Over the past decade, the interest in using exhaled gases
as non-invasive biomarkers in clinical diagnostics and
therapeutic monitoring has steadily increased [1]. Consid-
erable efforts have been made to determine clinically
applicable breath biomarkers for such conditions as
asthma, diabetes, and various cancers [2-7]. Evidence also
exists that cultivated microorganisms can generate species
or genus-specific profiles of VOCs [8-13]. Additionally,
unique gas signatures have been observed in the exhaled* Correspondence: hyewons@uci.edu
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in any medium, provided the original work is pbreath of patients with specific infections, including bron-
chopneumonia [14] and Helicobacter pylori [15].
Identifying and quantifying gases in the exhaled hu-
man breath provide a non-invasive means of obtaining
information about host responses to infection. However,
with the exception of nitric oxide, the cellular sources or
mechanisms responsible for the observed gases have not
been fully investigated. It is conceivable that the host im-
mune response may yield gases unique to one pathogen
or another. Escherichia Coli (E. coli) was used as a model
infectious organism to 1) determine the unique gas pro-
file of bacteria in a “naïve” state and 2) investigate the
VOCs that result from the bacteria and whole blood
interactions. VOC profiles found in the interaction of
bacteria and immune cells containing whole blood mayn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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breath gases from infected subjects.
A hermetically sealable bioreactor was used to grow
the cultures and collect the gaseous headspace. The
headspace was then analyzed for trace gases produced
and released by the microorganisms growing in culture
using a multi-column and multi-detector analytical gas
chromatography (GC) methodology [16].
This approach will soon be extended to additional in-
fectious agents and it is anticipated that the technology
will eventually demonstrate the capability to discrimin-
ate between multiple infectious pathogens by means of
their unique VOC profiles.
Methods
Blood Sampling. The blood was drawn using EDTA-
treated vacutainers from adult male subjects through the
Institute for Clinical Translational Sciences (ICTS) gen-
eral blood donor program. Subjects having a history of
any chronic medical conditions or use of any medica-
tions were excluded from the study. The Institutional
Review Board at the University of California, Irvine, ap-
proved the study.
E. Coli culture and headspace Gas collection
E. coli was purchased from Invitrogen (One Shot TOP10
Chemically Competent, Invitrogen, NY). The genotype
of this E. coli is similar to DH10B strain. The complete
genome sequence has been reported elsewhere (http://
www.ncbi.nlm.nih.gov/pubmed/18245285). Gibco LB broth
from Invitrogen was used for the study. The vials of E. coli-
inoculated whole blood (1 × 106 E. coli/10 mL whole blood)
and naïve E. coli inoculated LB broth (1 × 106 E. Coli/
10 mL LB) were placed inside bioreactors specifically
designed to collect the gaseous headspace above aque-
ous cultures [16]. For comparison, vials of LB broth only
(10 mL) or vials of whole blood only (10 mL) were also
placed inside bioreactors. To minimize ambient gaseous
contaminants, each bioreactor was flushed with whole
air containing low levels of VOCs and 5% CO2 for 10 mi-
nutes at 125 mL per minute. The bioreactors were then
placed in an incubator at 37°C for 24 hrs. The headspace
gases were collected after incubation and analyzed using
a gas chromatographic system with multiple column/
detector combinations [16-18]. Following sample collec-
tion, the bioreactor was disassembled and the cells were
immediately collected and counted.
GC system
The analyses of the headspace gases were performed on
a system previously developed to measure trace atmos-
pheric gases [17]. Briefly, a 233 cm3 (at STP) sample was
cryogenically pre-concentrated and injected into a multi-
column/detector GC system. The system consists ofthree Hewlett-Packard 6890 GC units (Wilmington, DE)
using a combination of columns and detectors capable of
separating and quantifying hundreds of gases, including,
but not limited to, non-methane hydrocarbons (NMHCs),
alkyl nitrates, and halocarbons in the ppbv to pptv range
(10-9 -10-12). The detectors include flame ionization detec-
tors (FIDs), electron capture detectors (ECDs), and a mass
selective detector (MSD). Preliminary identifications of
the unknown compounds were made using GC-MSD and
verification was obtained by injecting the diluted head-
space of pure compounds (Sigma-Aldrich, St. Louis, MO)
to ensure that both the elution time and the mass
spectrum matched that of the unknown.
Data analysis
Four study conditions, Broth only, Broth + E. coli, Blood
only, and Blood + E. coli were evaluated in each of the
10 experimental days. The same blood sample and E.
coli sample were used in the same day. A total of 117
gases were examined for each sample. Thirty-eight gases
were excluded; of these, 31 gases were below the limit of
detection in over 80% of the samples and seven gases
had concentrations less than 100 pptv in all samples. For
any gas that could not be detected in a sample, the level
was set to zero Wilcoxon signed-rank test, a non-
parametric method for paired data, was used to compare
the difference between Broth only and Broth + E. coli, be-
tween Blood only and Blood + E. coli, between Broth + E.
coli and Blood + E. coli, and between Broth only and
Blood only. The method was chosen because the sample
size was small, the distributions of most gases were highly
skewed, and the experiments performed on the same day
were considered more correlated than those performed on
different days. Multiple-comparison adjustment was fur-
ther applied using Benjamini and Hochberg’s false dis-
cover rate (FDR) method [19]. A comparison was
considered significant if FDR < 0.01. All analyses were
performed using SAS 9 (Cary, NC) and all data were
presented with median and range (minimum, maximum).
Results
After statistical analysis, 40 gases were allocated into five
categories based on the pattern of gas release: category 1:
VOCs elevated from E. coli-inoculated human whole
blood, (see Table 1 and Figure 1); category 2: VOCs ele-
vated from E. coli in LB broth (see Table 1 and Figure 2);
category 3: VOCs elevated from naïve E. coli in broth, but
decreased by E. coli-inoculated whole blood (see Table 1,
and Figure 3); category 4: VOCs mainly from pure LB
broth only (see Table 2 and Figure 4); category 5: VOCs
mainly from human whole blood only (see Table 3 and
Figure 5).
In category 1, there were six VOCs observed to be sig-
nificantly increased from E. coli-inoculated whole blood




+ E. coli + E. coli
Category 1: VOCs elevated in E. coli-infected blood
Diemthyl sulfide [pptv] 2,4 970 (310,2310) 16010 (180,29500) 3770 (1250,8820) 95920 (25740,234400)
Carbon disulfide [pptv] 2,3,4 85 (55,470) 295 (80,790) 4390 (2450,10040) 8940 (2620,16550)
Acetaldehyde [ppbv] 736 (558,1089) 645 (44,1359) 45 (22,145) 1158 (208,3493)
Ethanol [ppbv] 1,2,3 202 (28,564) 8388 (2037,10867) 218 (5,604) 15486 (7199,40441)
Unk S§ 2,3 31 (0,316) 74 (12,267) 675 (0,3311) 15001 (2208,37426)
Methyl Butanoate [pptv] 0 (0,25) 0 (0,40) 60 (0,405) 2675 (330,9720)
Category 2: VOCs elevated in naïve E. coli in LB broth
Isoprene [pptv] 1,4 0 (0,50) 1590 (665,2175) 1040 (350,2785) 1200 (455,2050)
Carbonyl sulfide (OCS) [pptv] 1 2240 (1440,4850) 8360 (4360,20180) 3850 (1970,22040) 6540 (3810,30340)
Unk R1§ 7474 (1568,42622) 116738 (15070,1005677) 3758 (105,20243) 2435 (785,10277)
Category 3: VOCs elevated in naïve E. coli but substantially lower from co-culture of E. coli and whole blood
Dimethyl disulfide [ppbv] 1,3,4 164 (133,185) 354 (182,537) 0.7 (0.3,2) 2 (0.6,4)
Methyl Propanoate [pptv] 3300 (2100,4300) 14500 (5660,21000) 400 (0,1400) 600 (0,1100)
Dimethyl trisulfide [pptv] 1,3 2900 (1900,9700) 160400 (22700,253300) 800 (10,6900) 400 (150,5400)
Unk_Q§ 2052 (0,13997) 57320 (6317,467654) 620 (0,6232) 289 (0,3787)
1-Propanol [pptv] 175 (0,90200) 757300 (472900,1920800) 700 (0,93600) 33400 (4100,90200)
Methylcylohexane [pptv] 220 (60,990) 1600 (850,3200) 130 (0,1720) 170 (80,980)
Unk R2§ 416 (0,5269) 15852 (2228,152789) 767 (0,9829) 674 (0,8522)
1: significantly different between Broth only and Broth + E. coli; 2: significantly different between Blood only and Blood + E. coli; 3: significantly different between
Broth + E. coli i and Blood + E. coli; 4: significantly different between Broth only and blood only.
Data were presented with median and range (minimum, maximum).
§unknown peaks were presented as area under the curve.
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These VOCs include dimethyl sulfide, carbon disulfide,
ethanol, acetaldehyde, methyl butanoate and an uniden-
tified gas S (see Table 1 and Figure 1 for examples of this
category). Ethanol was also emitted from the E. coli cul-
tured in the LB broth; however, the concentrations were
relatively small when compared to the E. coli-inoculated
whole blood (see Figure 1B).
In contrast, ten VOCs (see Table 1, category 2 and 3)
were significantly elevated from E. coli in LB broth
(Figures 2 and 3 show several examples). Isoprene, car-
bonyl sulfide (OCS), and unidentified gas peak R1 were
significantly elevated in the headspace of E. coli in LB
broth. These gases detected in the headspace of whole
blood, and E. coli-inoculated whole blood. However,
emitted isoprene, carbonyl sulfide and unidentified gas
peak R1 levels from whole blood and E. coli-inoculated
whole blood were not different (see Figure 2). Interest-
ingly, seven out of these ten VOCs were substantially
lower in the presence of human whole blood (see
category 3 and Figure 3). These VOCs included di-
methyl disulfide, dimethyl trisulfide, methylpropanoate,
1-propanol, methylcyclohexane, and unidentified gas
peaks R2, and Q. The emitted levels from whole bloodand E. coli-inoculated whole blood were not different in
these seven gases.
Table 2 lists 16 VOCs that were observed to be signifi-
cantly higher in LB broth when compared to the levels
in whole blood (category 4). The emitted levels of 14 out
of total 16 gases in this category (except n-Propylbenzene
and unidentified gas peak M) were decreased in the pres-
ence of E. coli. Human whole blood emitted trace amount
of these gases, and the levels of these gases were not al-
tered in the presence of E. coli. Butanone levels in four dif-
ferent conditions (in the LB broth, in the E. coli in the LB
broth, human whole blood, and E. coli-inoculated whole
blood) are presented in Figure 4 as an example.
Table 3 lists eight VOCs that mainly originated from
human whole blood (category 5). The emitted levels of
these eight VOCs were substantially higher in the whole
blood only when compared to the levels in LB broth.
Interestingly, co-incubation of E. coli in human blood
did not alter the concentrations of the gases.
Many elevated whole blood compounds were also
detected in the headspace of the blood-collecting vacu-
tainer and were rejected as carried-over contaminants.
These include: styrene, 3-methylpentane, n-hexane, cyclo-
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Figure 1 Representative patterns of VOCs in Category 1. (A) DMS, (B) Ethanol, and (C) Methyl Butanoate emission from 4 different
conditions: broth only (Br), E. coli in LB broth (Br + E. coli), whole blood only (B), and E. coli-inoculated whole blood (B + E. coli). 1. significantly
different between Broth only and Broth + E. coli; 2: significantly different between Blood only and Blood + E. coli; 3: significantly different
between Broth + E. coli and Blood + E. coli; 4: significantly different between Broth only and blood only.
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Specific VOCs released by E. coli in either LB broth or
human blood were collected and compared to the levels
emitted from LB broth or blood alone. Headspace gas
samples were collected after incubation for 24 hr at 37°C
from 10 mL samples inoculated with (or without)106 E.
coli. This study demonstrates 1) that cultivated E. coli in
LB broth produces distinct gas profiles, 2) for the first
time the ability to modify E. coli-specific gas profiles by
the addition of whole human blood (i.e., Methyl Pro-
panoate was highly emitted from E. coli in LB broth, but
barely detected in human whole blood), and 3) of most
significance, that the data suggests that E. coli-human
whole blood interaction has different gas emission profilesthat can be used as non-invasive markers of E. coli infec-
tion (i.e., methyl butanoate).
The co-culture of E. coli in human whole blood emitted
appreciable amounts of dimethyl sulfide when compared
to the level from naive E. coli in the LB broth (Figure 1A).
Dimethyl sulfide is a sulfur-containing odorous gas known
to be released from marine phytoplankton and algae, and
its release has been reported to protect algae and phyto-
plankton against environmental changes in salinity, ra-
diation, and temperature [20,21]. Dimethyl sulfide
released from damaged phytoplankton has also been
proposed to act as a deterrent, or chemical weapon,
against consumption by zooplankton [22]. In addition, it
has been proposed that some microorganisms are able




















































Figure 2 Representative patterns of VOCs in Category 2. (A) Isoprene and (B) carbonyl sulfide (OCS) emission from 4 different conditions:
only (Br), E. coli in LB broth (Br + E. coli), whole blood only (B), and E. coli-inoculated whole blood (B + E. coli). 1: significantly different between
Broth only and Broth + E. coli i; 2: significantly different between Blood only and Blood + E. coli i; 3: significantly different between Broth + E. coli
and Blood + E. coli; 4: significantly different between Broth only and blood only.
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http://www.clintransmed.com/content/2/1/13to generate gaseous dimethyl sulfide from dimethylsul-
phoniopropionate [23-25]. A significant concentration
of dimethyl sulfide was observed in the headspace of E.
coli-inoculated whole blood, whereas the headspace of
E. coli in LB broth contained much less dimethyl sulfide
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Figure 3 Representative patterns of VOCs in Category 3. (A) Dimethyl
conditions such as broth only (Br), E. coli in LB broth (Br + E. coli), whole bl
significantly different between Broth only and Broth + E. coli; 2: significantly
different between Broth + E. coli and Blood + E. coli; 4: significantly differeninoculated human whole blood produces dimethyl sul-
fide. Allardyce and colleagues reported that dimethyl
sulfide was detected from E. coli culture using BacT/
ALERT, which contains a mixture of media with blood
[8,26]. It is interesting to speculate the possible roles for
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1  (p<0.01) 3 (p< 0.01)
disulfide (DMDS) and (B) 1-propanol emission from 4 different
ood only (B), and E. coli-inoculated whole blood (B + E. coli). 1:
different between Blood only and Blood + E. coli; 3: significantly
t between Broth only and blood only.
Table 2 Gases mainly from pure broth
Gas Category 4 Gases mainly from LB broth (significantly higher in broth only compared to whole blood only)
Broth Blood
+ E. coli + E. coli
Ethyl nitrate [pptv] 429 (371, 448) 233 (32,284) 28 (17,38) 28 (21,35)
Methyl nitrate [pptv] 705 (670, 825) 446 (38,534) 29 (27,35) 29 (26,36)
2-Propyl nitrate [pptv] 162 (147,177) 103 (30,125) 20 (14,29) 20 (18,33)
2-Methylpropanal [pptv] 90900 (56900,203300) 4300 (700,8900) 2010 (100,600) 600 (200,1300)
3-Methylhexane [pptv] 2000 (1120, 3290) 1020 (660,1660) 510 (400,1850) 530 (220,1410)
2,2,4-Trimethylpentane [pptv] 9140 (8030, 9940) 6100 (1660,7140) 700 (360,1220) 810 (620,1160)
n-Decane [pptv] 100 (70,140) 50 (30,50) 60 (30,70) 60 (30,80)
Benzene [pptv] 93640 (50700,114580) 25910 (300,72270) 1100 (0,2070) 1030 (440,1550)
Toluene [pptv] 98930 (54460,129080) 30870 (1850,69270) 1210 (670,2420) 1680 (720,1880)
Ethylbenzene [pptv] 640 (250,950) 220 (40,530) 150 (80,280) 170 (120,290)
Styrene [pptv] 1130 (670,1950) 800 (290,1180) 280 (140,1110) 360 (200,820)
n-Propylbenzene [pptv] 40 (20,70) 40 (20,110) 20 (5,40) 30 (15,70)
Butanal [pptv] 169900 (60100,238800) 0 (0,8900) 700 (200,17100) 600 (0,34500)
Hexanaldehyde [pptv] 1250 (700,3800) 485 (275,1600) 450 (250,3050) 575 (175,2150)
Butanone [pptv] 478800 (374600,707000) 339600 (219900,555700) 5600 (2300,15900) 9500 (6400,31200)
Unk M§ 10530 (5841,20041) 12854 (7971,44834) 1095 (263,2664) 1633 (359,3345)
Data were presented with median and range (minimum, maximum).
§unknown peaks were presented as area under the curve.
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mediator of survival of blood cells in response to the
stresses of bacterial infection or the response of E. coli
in the face of the bactericidal components of whole
blood. Other studies utilizing different media/broth toButanone
























Figure 4 Butanone emission from 4 different conditions such
as broth only (Br), E. coli in LB broth (Br + E. coli), whole blood
only (B), and E. coli -inoculated whole blood (B + E. coli).
Butanone is an exemplary gas that originates from LB broth.culture E. coli did not observe dimethyl sulfide in the
headspace above the culture [9,13].
Various strains of E. coli have been reported to
metabolize glucose (and other sugars) to generate ethanol
regardless of culture medium or broth used [3,27-34]. In
the current study, ethanol has been detected in E. coli in
LB broth and in the presence of human whole blood
(Figure 1B). E. coli in LB broth emitted greater than 8
ppmv ethanol. The emission level was even greater (>15
ppmv) when E. coli was mixed with human blood. It is
likely that the ethanol emission from E. coli depends on
the available glucose in the LB broth or human whole
blood.
Acetaldehyde has previously been detected in exhaled
human breath [35,36] and in human lung cancer cell line
cultures [37-39]. We previously demonstrated that both
malignant myelocytic white blood cells such as HL60
and neutrophils are capable of producing acetaldehyde
(16;18). The current study also demonstrates that E.
coli-inoculated whole blood obtained from healthy sub-
jects emitted appreciable amounts of acetaldehyde into
the gas phase greater than the emission from whole blood
(Table 1). In addition, acetaldehyde has been detected
from other strains of E. coli and other microorganisms
such as Pseudomonas cultured in human blood and
medium mixture [8,26]. The LB broth itself also emits
some acetaldehyde. However, the levels were not altered
in the presence of E. coli in LB broth. This observation
Table 3 Gases mainly from whole human blood
Gas Category 5 Gases mainly from whole human blood (significantly higher in whole blood only compared
to broth only)
Broth Blood
+ E. coli + E. coli
n-Pentane [pptv] 50 (0,160) 10 (0,165) 1220 (835,1900) 1625 (815,2440)
Methanol [ppbv] 48 (34,132) 62 (41,110) 300 (210,346) 378 (226,704)
n-Heptane [pptv] 0 (0,315) 150 (30,165) 370 (260,915) 700 (210,4305)
2,3,4-Trimethylpentane [pptv] 35 (0,130) 55 (0,205) 125 (105,275) 145 (130,365)
alpha-Pinene [pptv] 5 (0,15) 5 (0,60) 40 (20,220) 60 (15,370)
Methyl chloride (CH3Cl) [pptv] 1045 (800,1390) 1140 (675,1815) 2190 (1215,2670) 1890 (1235,3025)
Dibromomethane (CH2Br2) [pptv] 1 (0,2) 1 (0,2) 47 (11,75) 54 (10,106)
i-Pentane [pptv] 225 (0,870) 210 (0,510) 1400 (545,2395) 1310 (0,4770)
Data were presented with median and range (minimum, maximum).
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http://www.clintransmed.com/content/2/1/13and others may suggest that acetaldehyde is likely a meta-
bolic byproduct of the interaction between E. coli and the
various components of whole blood [40,41].
Other VOCs generated only in the E. coli-inoculated
whole blood were methyl butanoate and a gas that re-
mains unidentified, unknown S. Methyl butanoate has
been detected in the exhaled breath of patients with liver
disorders [42]. These gases have the potential to be
breath biomarkers of E. coli infection since these VOCs
only appear in the E. coli-inoculated whole blood.
There were four VOCs found in the headspace above
cultured E. coli in LB broth that were significantly loweri-Pentane





















Figure 5 i-Pentane emission from 4 different conditions such as
broth only (Br), E. coli in LB broth (Br + E. coli), whole blood
only (B), and E. coli-inoculated whole blood (B + E. coli).
i-Pentane is an exemplary gas that originates from human
whole blood.in the presence of human whole blood. These VOCs in-
clude 1-propanol and the unknown VOCs R1, R2, and Q
(see Table 1). Note that both LB broth and human whole
blood generate negligible amounts of these VOCs. It re-
mains unclear whether these VOCs are produced by E.
coli and metabolized by certain components in the blood
or the gas production itself was suppressed in the blood.
One such possible mechanism for 1-propanal would be
the production of 1-propanol by E. coli [43] and then,
when co-cultured with whole blood, 1-propanol is me-
tabolized by alcohol dehydrogenase in the human whole
blood [44]. These compounds may prove interesting in
cellular mechanistic studies as they have potentially been
catabolised by E. coli and/or whole blood.
Isoprene, carbonyl sulfide, and unidentified gas peak
R1 were higher in the headspace of E. coli in LB broth
when compared to the LB broth only. carbonyl sulfide
has been detected in the human breath [14]. Breath car-
bonyl sulfide concentrations were significantly higher in
subjects with cystic fibrosis and it has been suggested
that it originates from respiratory bacterial colonization.
In effect, subjects with poorer pulmonary function
tended to have greater breath carbonyl sulfide concen-
trations [14]. Isoprene has also been detected in exhaled
human breath, and its possible association with blood
cholesterol levels [45,46] and end-stage renal failure [47]
has been suggested. In addition, various bacterial spe-
cies, including E. coli, have been reported to produce
isoprene, though emitted isoprene levels varied depend-
ing on the culture medium [48]. In the current study, E.
coli contributes to isoprene emission with median value
of 1600 pptv when cultured in the LB broth. Human
whole blood obtained from healthy subjects emitted a
median value of 1000 pptv of isoprene. Interestingly, E.
coli inoculation into the whole blood does not affect
emitted isoprene levels. This observation may suggest
that isoprene release may be governed by different
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human whole blood.
In contrast, there are certain VOCs that originated
from LB broth only or human whole blood only that are
not increased by the addition of E. coli (Table 2, category
4 and Figure 4; Table 3, category 5 and Figure 5). For ex-
ample, butanone (an exemplary gas, category 4) and i-
Pentane (an exemplary gas, category 5) emissions were
observed either in LB broth only or human whole blood
only, respectively. However, the emission levels were not
altered in the presence of E. coli; the VOCs under these
categories were not considered of interest in searching
for E. coli -associated gas biomarkers.
Conclusions
The current study demonstrates that cultivated E. coli
produces distinct gas profiles depending on the medium
used (i.e., LB broth or human whole blood). In addition,
and of most significance, the data suggests that the inter-
action between E. coli and human whole blood presents a
different gas emission profile that may have the potential
to be used as non-invasive marker of E. coli infection.
Additional investigations will be required to provide a
more specific understanding of how the immune response
of whole blood specifically alters the gas signature of in-
vading E. coli. These data also provide the beginning of an
inventory of VOCs associated with E. coli –the necessary
first step from which an exploration of other pathogenic
microorganisms can follow.
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